SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-067694
Filing Date
2018-11-13
Accepted
2018-11-13 07:10:50
Documents
2
Period of Report
2018-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-40092_18k.htm 8-K 27805
2 EX-99.1 a18-40092_1ex99d1.htm EX-99.1 80925
  Complete submission text file 0001104659-18-067694.txt   109923
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 181175051
SIC: 2834 Pharmaceutical Preparations